Packaging for the medical products market presents unique challenges to the industry. Pharmaceutical safety, product quality and supply chain traceability must be maintained without compromise. At the same time, pressure is building for sustainability improvements. Businesses are now dealing with meeting these demands together. New legislation is coming into force in the US stipulating how drugs should be packaged, tracked and transported. The Drug Supply Chain Security Act (DSCSA), first approved in 2013, outlines steps to achieve an interoperable and electronic way to identify and trace certain prescription drugs through packaging. It is designed to allow the US Food and Drug Administration (FDA) to know where pharmaceutical products are at any time throughout the country. Next year, distributors, manufacturers and repackers will be obliged to abide by these regulations.
